Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
IRON Disc Medicine Inc
- Stocks
- Healthcare
- NASDAQ: IRON
Price (delayed)
$54.75
Market cap
$1.9B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.92
Enterprise value
$1.8B
Highlights
IRON's equity has soared by 95% year-on-year and by 49% since the previous quarter
Disc Medicine's quick ratio has soared by 76% from the previous quarter and by 61% YoY
Disc Medicine's net income has decreased by 45% YoY and by 7% QoQ
IRON's EPS is down by 16% YoY
Key stats
What are the main financial stats of IRON
Market
Valuations
Earnings
Shares outstanding
34.63M
Market cap
$1.9B
Enterprise value
$1.8B
Price to earnings (P/E)
N/A
Price to book (P/B)
2.87
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$138.2M
Net income
-$116.49M
EBIT
-$114.56M
EBITDA
-$114M
Free cash flow
-$102.99M
Per share
Balance sheet
Liquidity
EPS
-$3.92
EPS diluted
-$3.92
Free cash flow per share
-$3.09
Book value per share
$19.1
Revenue per share
$0
TBVPS
$21.28
Total assets
$709.27M
Total liabilities
$48.9M
Debt
$30.64M
Equity
$660.36M
Working capital
$686.86M
Debt to equity
0.05
Current ratio
37.65
Quick ratio
37.07
Net debt/EBITDA
0.81
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-21.1%
Return on equity
-22.6%
Return on invested capital
-32.7%
Return on capital employed
-16.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IRON stock price
How has the Disc Medicine stock price performed over time
Intraday
2.97%
1 week
1.15%
1 month
15.51%
1 year
23.23%
YTD
-13.64%
QTD
3.38%
Financial performance
How have Disc Medicine's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$138.2M
Net income
-$116.49M
Gross margin
N/A
Net margin
N/A
Disc Medicine's net income has decreased by 45% YoY and by 7% QoQ
The operating income has declined by 42% year-on-year and by 7% since the previous quarter
Price vs fundamentals
How does IRON's price correlate with its fundamentals
Growth
What is Disc Medicine's growth rate over time
Valuation
What is Disc Medicine stock price valuation
P/E
N/A
P/B
2.87
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
IRON's EPS is down by 16% YoY
IRON's equity has soared by 95% year-on-year and by 49% since the previous quarter
IRON's price to book (P/B) is 26% lower than its 5-year quarterly average of 3.9 and 7% lower than its last 4 quarters average of 3.1
Efficiency
How efficient is Disc Medicine business performance
Disc Medicine's ROIC has increased by 40% from the previous quarter
Disc Medicine's return on assets has increased by 11% QoQ and by 2.8% YoY
The ROE rose by 10% QoQ
Dividends
What is IRON's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IRON.
Financial health
How did Disc Medicine financials performed over time
The total assets has surged by 100% year-on-year and by 43% since the previous quarter
The current ratio has soared by 78% from the previous quarter and by 59% YoY
The company's debt is 95% lower than its equity
IRON's equity has soared by 95% year-on-year and by 49% since the previous quarter
IRON's debt to equity is down by 29% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.